Pharmaceutical Research and Manufacturers of America California Initiative Fund

$183.61M 2025-2026 cycle

Pharmaceutical Research and Manufacturers of America California Initiative Fund is a political services vendor. In the 2025-2026 cycle Pharmaceutical Research and Manufacturers of America California Initiative Fund was paid $183.61M across 3 client committees, of which $99.45M flowed through Independent Expenditures rather than direct committee payments.

○ Slowing (~4mo since last)
Limited recent activity. Most recent disbursement to this vendor was 4 months ago (May 8, 2026). Charts below reflect cycle-to-date totals; the recent windows may be sparse.

Part I Identity

Stable facts about this entity. These figures do not change as you adjust the timeframe in Part II.

Source split

$183.61M = $84.16M (Schedule B) + $99.45M (Independent Expenditures)
Schedule B
direct committee payments
$84,163,300 95 rows 45.8%
Independent Expenditures
money this entity spent supporting candidates, NOT a committee paying them
$99,446,295 109 rows 54.2%
Activity span ALL TIME
Feb 8, 2005 → May 8, 2026
spans 21.2 years
Disbursements ALL TIME
95
Schedule B + IE rows
Client committees ALL TIME
3
distinct payers

Part II Activity in selected window

One timeframe control governs all three panels below. Change it once and the trajectory, top buyers, and party breakdown all update together.

Spend trajectory

Monthly spend to this vendor over the last 12 months.

Jun 2025 May 2026
$90K across 12 months
#

Top buyers

Two views of the same data — diagram and table share the time-window control and the same top-buyers slice. Click "View all buyers in research" to drill in with the matching date range.

No buyer activity in this window.

No buyer activity in this window.

VIEW 1 DIAGRAM DECORATIVE

Top buyers last 6 months · top 1

NO ON PROP 61 - CALIFORNIANS AGAINST … $100K — · 10 txns PR Pharmaceutical Research and Manu…
VIEW 1 DIAGRAM DECORATIVE

Top buyers last 12 months · top 1

NO ON PROP 61 - CALIFORNIANS AGAINST … $160K Other / Unclassified · 16 txns PR Pharmaceutical Research and Manu…
VIEW 1 DIAGRAM DECORATIVE

Top buyers last 18 months · top 1

NO ON PROP 61 - CALIFORNIANS AGAINST … $330K Other / Unclassified · 33 txns PR Pharmaceutical Research and Manu…
VIEW 1 DIAGRAM DECORATIVE

Top buyers last 24 months · top 1

NO ON PROP 61 - CALIFORNIANS AGAINST … $370K Other / Unclassified · 37 txns PR Pharmaceutical Research and Manu…

By party

PartyAmount%
Democratic $0 0.00%
Republican $0 0.00%
Non-partisan $183,609,595 100.00%

Part III Reference tables

Full all-time and cycle-to-date data.

#
#

Money flow through this vendor

Where their ad buys point

IE payers (left) → races the buys targeted (right) · independent-expenditure filings only

No activity in the last 1 months.

No activity in the last 3 months.

Pharmaceutical Research and Man… NO ON PROP 61 - CALIFORNIAN… $50K Unspecified races (5 filing… $50K Total in: $50K Total out: $50K
Pharmaceutical Research and Man… NO ON PROP 61 - CALIFORNIAN… $80K Unspecified races (8 filing… $80K Total in: $80K Total out: $80K
Pharmaceutical Research and Man… NO ON PROP 61 - CALIFORNIAN… $170K Unspecified races (17 filin… $170K Total in: $170K Total out: $170K
Pharmaceutical Research and Man… NO ON PROP 61 - CALIFORNIAN… $190K Unspecified races (19 filin… $190K Total in: $190K Total out: $190K
#

Cycle-over-cycle trajectory

2020202120222023202420252026 Q1 2020 (2020 cycle): $37KQ2 2020 (2020 cycle): $12KQ1 2021 (2020 cycle): $48KQ2 2021 (2020 cycle): $24KQ3 2021 (2020 cycle): $12KQ4 2021 (2020 cycle): $12KQ1 2022 (2022 cycle): $48KQ2 2022 (2022 cycle): $12KQ3 2022 (2022 cycle): $24KQ1 2023 (2022 cycle): $55KQ2 2023 (2022 cycle): $33KQ1 2024 (2024 cycle): $5KQ2 2024 (2024 cycle): $10KQ1 2025 (2024 cycle): $50KQ2 2025 (2024 cycle): $50KQ1 2026 (2026 cycle): $50KQ2 2026 (2026 cycle): $30K Q1Q1Q3Q1Q3Q2Q2Q2Q2 $55K

current cycle earlier election cycle off-cycle year quarterly · 7 years

Per-quarter totals
Year Q Cycle Total Txns Top buyer · share Top category · share Cum. (cycle) YoY %
2020 Q1 2020 $37K 3 NO ON PROP 61 - CALIFORNIAN… 100% Other / Unclassified 100% $37K
2020 Q2 2020 $12K 1 NO ON PROP 61 - CALIFORNIAN… 100% Other / Unclassified 100% $49K
2021 Q1 2020 $48K 4 NO ON PROP 61 - CALIFORNIAN… 100% Other / Unclassified 100% $96K
2021 Q2 2020 $24K 2 NO ON PROP 61 - CALIFORNIAN… 100% Other / Unclassified 100% $120K
2021 Q3 2020 $12K 1 NO ON PROP 61 - CALIFORNIAN… 100% Other / Unclassified 100% $132K
2021 Q4 2020 $12K 1 NO ON PROP 61 - CALIFORNIAN… 100% Other / Unclassified 100% $144K
2022 Q1 2022 $48K 4 NO ON PROP 61 - CALIFORNIAN… 75% Other / Unclassified 100% $48K +30%
2022 Q2 2022 $12K 1 NO ON PROP 61 - CALIFORNIAN… 100% Other / Unclassified 100% $60K -2%
2022 Q3 2022 $24K 2 NO ON PROP 61 - CALIFORNIAN… 100% Other / Unclassified 100% $83K
2023 Q1 2022 $55K 5 NO ON PROP 61 - CALIFORNIAN… 100% Other / Unclassified 100% $138K +14%
2023 Q2 2022 $33K 3 NO ON PROP 61 - CALIFORNIAN… 100% Other / Unclassified 100% $171K +37%
2024 Q1 2024 $5K 1 NO ON PROP 61 - CALIFORNIAN… 100% Other / Unclassified 100% $5K -89%
2024 Q2 2024 $10K 2 NO ON PROP 61 - CALIFORNIAN… 100% Other / Unclassified 100% $15K -16%
2025 Q1 2024 $50K 5 NO ON PROP 61 - CALIFORNIAN… 100% Other / Unclassified 100% $65K -8%
2025 Q2 2024 $50K 5 NO ON PROP 61 - CALIFORNIAN… 100% Other / Unclassified 100% $115K +53%
2026 Q1 2026 $50K 5 NO ON PROP 61 - CALIFORNIAN… 100% Other / Unclassified 20% $50K +900%
2026 Q2 2026 $30K 3 NO ON PROP 61 - CALIFORNIAN… 100% $80K +200%
#

Revenue by service category

No category revenue in this window.

No category revenue in this window.

No category revenue in this window.

No category revenue in this window.

No category revenue in this window.

No category revenue in this window.

Per-category breakdown · cycle-to-date
Category Total spend Txns Avg check % of total Top buyer · share Last paid
Other / Unclassified $79,544,800 86 $925K 94.6% PHARMACEUTICAL RESEARCH AND… 47% 6mo ago
Contributions & Transfers $4,548,500 2 $2.27M 5.4% PHARMACEUTICAL RESEARCH AND… 100% 21y ago
#

Client retention

Sticky-relationship signal: how many clients keep coming back across cycles vs one-time buyers.

2
Anchor clients 3+ cycles
$74,285,200 · 88% of revenue
1
Repeat clients 2 cycles
$9,878,100 · 12% of revenue
0
One-time clients 1 cycle
$0 · 0% of revenue
Top 2 anchor clients · all-time
#

Geographic concentration

Where this vendor's clients are based — federal committees by state, plus implicit jurisdiction for CA and TX state filers.

State   Total spend % of revenue Clients
CA
$84,163,300 100.0% 3
#

Notable disbursements

5 largest all-time · 5 largest in the current cycle · 5 most recent. Each row earns its place.

Reason Date Filer Category Purpose Amount
Largest all-time 2005-06-21 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA CALIFORNIA INITIATIVE FUND Other / Unclassified $8,541,600
Largest all-time 2005-07-15 484275 Other / Unclassified $8,540,600
Largest all-time 2005-06-30 PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMERICA CALIFORNIA INITIATIVE FUND Other / Unclassified 2005 Contribution $8,540,600
Largest all-time 2016-12-02 NO ON PROP 61 - CALIFORNIANS AGAINST THE DECEPTIVE RX PROPOSITION, A COALITION OF VETERANS DOCTORS PATIENT ADVOCATES SENIORS TAXPAYERS AND MEMBERS OF PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMER. Other / Unclassified $5,700,000
Largest all-time 2015-09-29 NO ON PROP 61 - CALIFORNIANS AGAINST THE DECEPTIVE RX PROPOSITION, A COALITION OF VETERANS DOCTORS PATIENT ADVOCATES SENIORS TAXPAYERS AND MEMBERS OF PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMER. Other / Unclassified $5,700,000
Largest this cycle 2026-05-08 NO ON PROP 61 - CALIFORNIANS AGAINST THE DECEPTIVE RX PROPOSITION, A COALITION OF VETERANS DOCTORS PATIENT ADVOCATES SENIORS TAXPAYERS AND MEMBERS OF PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMER. $10,000
Largest this cycle 2026-03-10 NO ON PROP 61 - CALIFORNIANS AGAINST THE DECEPTIVE RX PROPOSITION, A COALITION OF VETERANS DOCTORS PATIENT ADVOCATES SENIORS TAXPAYERS AND MEMBERS OF PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMER. $10,000
Largest this cycle 2026-03-10 NO ON PROP 61 - CALIFORNIANS AGAINST THE DECEPTIVE RX PROPOSITION, A COALITION OF VETERANS DOCTORS PATIENT ADVOCATES SENIORS TAXPAYERS AND MEMBERS OF PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMER. $10,000
Largest this cycle 2026-05-07 NO ON PROP 61 - CALIFORNIANS AGAINST THE DECEPTIVE RX PROPOSITION, A COALITION OF VETERANS DOCTORS PATIENT ADVOCATES SENIORS TAXPAYERS AND MEMBERS OF PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMER. $10,000
Largest this cycle 2026-02-13 NO ON PROP 61 - CALIFORNIANS AGAINST THE DECEPTIVE RX PROPOSITION, A COALITION OF VETERANS DOCTORS PATIENT ADVOCATES SENIORS TAXPAYERS AND MEMBERS OF PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMER. $10,000
Recent 2026-05-07 NO ON PROP 61 - CALIFORNIANS AGAINST THE DECEPTIVE RX PROPOSITION, A COALITION OF VETERANS DOCTORS PATIENT ADVOCATES SENIORS TAXPAYERS AND MEMBERS OF PHARMACEUTICAL RESEARCH AND MANUFACTURERS OF AMER. $10,000
9 raw FEC name variants collapsed into this canonical entity
See all 95 disbursements →